Archive for the 'Administrative' Category

SSI Names 2010 “Clean Hands Award” Recipient

26 Oct – Nashville - The Board of Directors is proud to announce that Dr. Richard Willner DPM, is the Semmelweis Society International “Clean Hands Award” recipient for 2010. Continue reading ‘SSI Names 2010 “Clean Hands Award” Recipient’


15 AugCentral Louisiana Politics and the Rapides Parish Legal Recorder report that a $3,900,00.00 judgement was awarded to Dr. Tommie Granger against Christus Health Central.  After a jury trial, the jury awarded Dr. Granger that sum for unfair or deceptive trade practises and for a negligent misrepresentation of facts to Christus’ peer review action. See the jury’s special verdict form HERE.

Dr. Granger’s attorney, Jimmy Faircloth, Jr., in the case which has been ongoing since 2003, also has requested $79,644.80 in expert fees and court reporter costs. (See: Memorandum in Support of Plaintiff’s Motion to Tax Costs).

Christus’ attorney was Ron Fiorenza or the law firm of Provosty, Sadler, deLaunay, Fiorenza & Sobel.

SSI Welcomes New Members!

Semmelweis Society International is proud to welcome its newest members. Because of their membership and support, SSI continues to assist physicians throughout the US.

Most notably, SSI has prepared this Amicus Brief on behalf of Dr. Rakesh Wahi, whose case may be one of the most important case regarding the issue of “sham peer review” to reach the US Supreme Court. In the next few weeks, SSI will provide more information about the case.

SSI’s newest members include:

Barnes, M. Journalist
Bowen, A. DO
Conte, D.
Costa, L. DO
Daniels, D. MD
Estela, J. MD
Evans, C. MD
Filtzer, H. MD
Gambrill, E. PhD
Geenens, D. MD
Griffith, P. MD
Heusinkveld, J. MD
Martell, C. MD
Mercado-Deane, M. MD
Natchez, T. MD
Nazir, T. PhD
Wacker, M. MD

With their continued assistance and support, SSI will remain a strong voice on the issues of patient safety and integrity in the healthcare industry.

Congratulations to all!

Message to Members

Over the past months, some of our members and associates have asked SSI to post things they’ve written. While we found the content of their essays important, their value was eroded by marginal writing.

Professional journalists and investigators know that the most important investigation is meaningless if recorded in sloppy or illegible reports.

Unfortunately, some of our most passionate medical reform advocates have spent so much time writing like doctors that their content is almost entirely lost in a sea of awkward paragraphs, redundancy, and unnecessarily verbose, disjointed, bombastic, de trop, diffuse, extra, extravagant, inessential, inordinate, iterating, long-winded, loquacious, oratorical, padded, palaverous, periphrastic, pleonastic, prolix, reiterating, spare, supererogatory, superfluous, supernumerary, surplus, tautological, unnecessary, unwanted, wordy… SEE WHAT I MEAN!!!

Each of you brings a wealth of information and experience that others can learn from. Your perspective and passion is valued by our membership. After years in an academic or medical environment, you may experience residual fears that you might offend someone who can negatively affect your career. At Semmelweis, you’re free to write what you want, as long as it is relevant, coherent, and respectful. If you are concerned about retaliation, we can post your essays anonymously.

SSI offers three forums:

  • Our website offers a formal place where well-written essays, reports, and news events can be posted. Reasonably well-written and thoughtful reports will be posted, as will relevant news events that you want to see posted. If you find a news event, write a short paragraph explaining what you think is important and include the link.
  • Our blog is less formal, and writers can submit items with less formality. Remember that whatever you post reflects on you, SSI, and your profession. If your reports and essays look like they were written with crayons, it will reflect badly on us all.
  • Our forum is the least formal and allows you to post directly to the group. If you don’t have time to write a masterpiece, you can share your ideas with other members without too much sweat.

These are YOUR forums. They are fairly new and it may take a while before you get the hang of it. Comments are also encouraged – clink on the comments link. Feel free to share your observations, experiences, and alternative views with everyone.

Use this page to contact us for submissions.

JAMA Editor Calls Critic a ‘Nobody and a Nothing’

Editors of The Journal of the American Medical Association, better known as JAMA, can be a little thin-skinned when it comes to outsiders taking issue with studies published in the prestigious medical journal.

Jonathan Leo, a professor of neuro-anatomy at tiny Lincoln Memorial University in Harrogate, Tenn., posted a letter on the Web site of the British Medical Journal this month criticizing a study that appeared in JAMA last spring. The study concerned the use of the anti-depressant Lexapro in stroke patients. In addition to identifying what he said was an important omission in the paper — that behavioral therapy worked just as well as the drug when compared head to head in the study — Leo also pointed out that the lead author had a financial relationship with Forest Laboratories, the maker of Lexapro, that was not disclosed in the study.

Leo says he received an angry call from JAMA executive deputy editor Phil Fontanarosa last week, shortly after Leo’s article was published on the BMJ Web site. “He said, ‘Who do you think you are,’ ” says Leo. “He then said, ‘You are banned from JAMA for life. You will be sorry. Your school will be sorry. Your students will be sorry.” Fontanarosa referred a call for comment to a JAMA spokeswoman, who said Leo’s retelling of the conversation was “inaccurate.”  (more)

GAP Hosts National Whistleblower Events

(Washington) – As part of the National Whistleblower Assembly conference currently underway, the Government Accountability Project (GAP) will host a panel discussion on Capitol Hill examining the past, current, and future state of the controversy surrounding the warrantless wiretapping scandal.   

Further information about the panel and Whistleblower events can be found in this press release and the GAP website.